These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 16023971)

  • 1. Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
    Chevaliez S; Pawlotsky JM
    Clin Liver Dis; 2005 Aug; 9(3):371-82, v. PubMed ID: 16023971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical use of hepatitis C and B molecular tools: Belgian guidelines.
    Adler M; Goubau P; Leroux-Roels G; Sprengers D; Pawlotsky JM
    Acta Gastroenterol Belg; 2005; 68(3):308-13. PubMed ID: 16268416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory approaches to the diagnosis of hepatitis C virus infection.
    Jerome KR; Gretch DR
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):9-20. PubMed ID: 15719002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus diagnostics: technology, clinical applications and impacts.
    Conry-Cantilena C
    Trends Biotechnol; 1997 Feb; 15(2):71-6. PubMed ID: 9081301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and interpretation of virological tests for hepatitis C.
    Pawlotsky JM
    Hepatology; 2002 Nov; 36(5 Suppl 1):S65-73. PubMed ID: 12407578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Virological tools for the diagnosis and follow up of hepatitis C: use and role of new tests].
    Lunel-Fabiani F; Payan C
    Gastroenterol Clin Biol; 2003; 27(8-9):718-26. PubMed ID: 14586244
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis, evaluation, and treatment of HIV/HCV coinfection.
    Tedaldi E; Bean P
    Am Clin Lab; 2001; 20(9):26-32. PubMed ID: 11766416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Wiesner RH
    Hepatology; 2008 Dec; 48(6):1734-6. PubMed ID: 19026008
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV virological assessment.
    Forns X; Costa J
    J Hepatol; 2006; 44(1 Suppl):S35-9. PubMed ID: 16343682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seronegative hepatitis C virus infection, not just RNA detection.
    Stapleton JT; Schmidt WN; Katz L
    J Infect Dis; 2004 Aug; 190(3):651-2. PubMed ID: 15243946
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
    Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
    J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.